Yahoo

Correo

Mercados españoles cerrados en 26 mins

IBEX 35
11.297,80
-31,20(-0,28%)
Euro Stoxx 50
5.034,39
+9,22(+0,18%)
Dólar/Euro
1,0831
+0,0004(+0,03%)
Petróleo Brent
81,92
+0,02(+0,02%)
Oro
2.346,00
-46,90(-1,96%)
Bitcoin EUR
62.666,77
-2.087,21(-3,22%)

Edgewise Therapeutics, Inc. (EWTX)

NasdaqGS - NasdaqGS Precio en tiempo real. Divisa en USD

Añadir a la lista de favoritos

17,59

-0,59

(-3,22%)

A partir del 11:04AM EDT. Mercado abierto.

Accionistas principales

Lista de personas con información privilegiada

Transacciones de accionistas miembros de la empresa

Divisa en USD

Compras de personas con información privilegiada de los 6 últimos meses	Acciones	Trans
Compras	1.091.448	12
Ventas	325.158	11
Cuotas netas adquiridas (vendidas)	766.290	23
Acciones de persona con información privilegiada totales	439,91k	N/A
% de acciones netas adquiridas (vendidas)	-234,90%	N/A

Compras institucionales netas del trimestre anterior al último trimestre	Acciones
Cuotas netas adquiridas (vendidas)	N/A
% de cambio en la posesión de acciones institucionales	N/A

Transacciones comunicadas por la persona con información privilegiada: últimos dos años

Persona con información privilegiada	Transacción	Tipo	Valor	Fecha	Acciones
CARRUTHERS R MICHAEL Chief Financial Officer	Sale at price 18.91 per share.	Directo	40.789	02 may 2024	2.157
KOCH KEVIN Chief Executive Officer	Sale at price 18.91 per share.	Directo	59.604	02 may 2024	3.152
MOORE JOHN R General Counsel	Sale at price 18.91 per share.	Directo	36.988	02 may 2024	1.956
DONOVAN JOANNE M Officer	Sale at price 18.91 per share.	Directo	69.627	02 may 2024	3.682
DERAKHSHAN BEHRAD Officer	Sale at price 18.91 per share.	Directo	32.487	02 may 2024	1.718
RUSSELL ALAN J Officer and Director	Sale at price 18.91 per share.	Directo	29.802	02 may 2024	1.576
CARRUTHERS R MICHAEL Chief Financial Officer		Directo		01 may 2024	5.208
KOCH KEVIN Chief Executive Officer		Directo		01 may 2024	10.417
MOORE JOHN R General Counsel		Directo		01 may 2024	5.208
DONOVAN JOANNE M Officer		Directo		01 may 2024	10.417
DERAKHSHAN BEHRAD Officer		Directo		01 may 2024	5.208
RUSSELL ALAN J Officer and Director		Directo		01 may 2024	5.208
MOORE JOHN R General Counsel	Sale at price 20.00 - 20.01 per share.	Directo	596.805	09 feb 2024	29.835
MOORE JOHN R General Counsel	Conversion of Exercise of derivative security at price 1.93 per share.	Directo	57.582	09 feb 2024	29.835
DERAKHSHAN BEHRAD Officer	Sale at price 20.00 - 20.04 per share.	Directo	200.258	09 feb 2024	10.000
DERAKHSHAN BEHRAD Officer	Conversion of Exercise of derivative security at price 1.93 per share.	Directo	19.300	09 feb 2024	10.000
CARRUTHERS R MICHAEL Chief Financial Officer	Sale at price 15.78 per share.	Directo	1.419.759	23 ene 2024	90.000
CARRUTHERS R MICHAEL Chief Financial Officer	Conversion of Exercise of derivative security at price 1.93 per share.	Directo	173.700	23 ene 2024	90.000
THOMPSON PETER A Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 15.46 per share.	Indirecto	7.027.266	23 ene 2024	454.545
ORBIMED ADVISORS, L.L.C. Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 15.46 per share.	Indirecto	7.027.266	23 ene 2024	454.545
MOORE JOHN R General Counsel	Sale at price 10.50 per share.	Directo	89.218	27 dic 2023	8.497
FOX JONATHAN C Director	Purchase at price 9.30 per share.	Directo	100.958	26 dic 2023	10.857
RUSSELL ALAN J Officer and Director	Sale at price 9.33 per share.	Directo	1.610.097	26 dic 2023	172.585
CARRUTHERS R MICHAEL Chief Financial Officer	Conversion of Exercise of derivative security at price 0.71 per share.	Directo	7.100	22 jun 2023	10.000
CARRUTHERS R MICHAEL Chief Financial Officer	Sale at price 8.90 per share.	Directo	11.897	02 may 2023	1.336
KOCH KEVIN Chief Executive Officer	Sale at price 8.90 per share.	Directo	28.522	02 may 2023	3.203
MOORE JOHN R General Counsel	Sale at price 8.90 per share.	Directo	16.893	02 may 2023	1.897
DONOVAN JOANNE M Officer	Sale at price 8.90 per share.	Directo	28.977	02 may 2023	3.254
DERAKHSHAN BEHRAD Officer	Sale at price 8.90 per share.	Directo	15.557	02 may 2023	1.747
RUSSELL ALAN J Officer and Director	Sale at price 8.90 per share.	Directo	14.266	02 may 2023	1.602
CARRUTHERS R MICHAEL Chief Financial Officer		Directo		01 may 2023	5.208
KOCH KEVIN Chief Executive Officer		Directo		01 may 2023	10.416
MOORE JOHN R General Counsel		Directo		01 may 2023	5.208
DONOVAN JOANNE M Officer		Directo		01 may 2023	10.416
DERAKHSHAN BEHRAD Officer		Directo		01 may 2023	5.208
RUSSELL ALAN J Officer and Director		Directo		01 may 2023	5.208
MOORE JOHN R General Counsel	Sale at price 9.76 per share.	Directo	46.155	03 oct 2022	4.730
MOORE JOHN R General Counsel	Conversion of Exercise of derivative security at price 1.93 per share.	Directo	9.129	03 oct 2022	4.730
THOMPSON PETER A Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 10.32 per share.	Indirecto	4.999.999	16 sept 2022	484.496
ORBIMED ADVISORS, L.L.C. Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 10.32 per share.	Indirecto	4.999.999	16 sept 2022	484.496
NOVO HOLDINGS A/S Beneficial Owner of more than 10% of a Class of Security	Purchase at price 10.32 per share.	Directo	4.999.999	14 sept 2022	484.496
MOORE JOHN R General Counsel	Sale at price 10.83 - 10.99 per share.	Directo	51.598	06 sept 2022	4.730
MOORE JOHN R General Counsel	Conversion of Exercise of derivative security at price 1.93 per share.	Directo	9.129	06 sept 2022	4.730
MOORE JOHN R General Counsel	Sale at price 9.31 per share.	Directo	85.921	03 ago 2022	9.232
MOORE JOHN R General Counsel	Conversion of Exercise of derivative security at price 0.71 - 1.93 per share.	Directo	12.325	03 ago 2022	9.232
MOORE JOHN R General Counsel	Sale at price 8.35 - 8.54 per share.	Directo	77.256	06 jul 2022	9.232
MOORE JOHN R General Counsel	Conversion of Exercise of derivative security at price 0.71 - 1.93 per share.	Directo	12.325	06 jul 2022	9.232
MOORE JOHN R General Counsel	Sale at price 6.17 - 7.29 per share.	Directo	463.935	21 jun 2022	67.927
MOORE JOHN R General Counsel	Conversion of Exercise of derivative security at price 0.71 - 1.93 per share.	Directo	114.619	21 jun 2022	67.927
MOORE JOHN R General Counsel	Sale at price 6.01 - 6.11 per share.	Directo	160.457	15 jun 2022	26.381
MOORE JOHN R General Counsel	Conversion of Exercise of derivative security at price 0.71 - 1.93 per share.	Directo	19.444	15 jun 2022	26.381
MOORE JOHN R General Counsel	Sale at price 6.05 - 6.63 per share.	Directo	175.878	10 jun 2022	27.306
MOORE JOHN R General Counsel	Conversion of Exercise of derivative security at price 0.71 per share.	Directo	19.387	10 jun 2022	27.306
MOORE JOHN R General Counsel	Sale at price 6.03 - 6.61 per share.	Directo	295.985	07 jun 2022	47.287
MOORE JOHN R General Counsel	Conversion of Exercise of derivative security at price 0.71 - 1.93 per share.	Directo	70.341	07 jun 2022	47.287
CARRUTHERS R MICHAEL Chief Financial Officer	Conversion of Exercise of derivative security at price 0.71 per share.	Directo	6.390	23 may 2022	9.000
THOMPSON PETER A Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 7.21 per share.	Indirecto	994.980	18 may 2022	138.000
ORBIMED ADVISORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 7.21 per share.	Indirecto	994.980	18 may 2022	138.000
MOORE JOHN R General Counsel	Sale at price 7.42 per share.	Directo	80.146	16 may 2022	10.800
MOORE JOHN R General Counsel	Conversion of Exercise of derivative security at price 0.71 per share.	Directo	3.834	21 ene 2022	5.400
MOORE JOHN R General Counsel	Conversion of Exercise of derivative security at price 0.71 per share.	Directo	3.834	28 dic 2021	5.400
RUSSELL ALAN J Officer	Conversion of Exercise of derivative security at price 0.18 - 0.45 per share.	Directo	37.815	30 nov 2021	172.585
RUSSELL ALAN J Officer and Director	Sale at price 19.07 - 19.61 per share.	Directo	9.155	15 nov 2021	479
RUSSELL ALAN J Officer	Sale at price 19.51 - 20.43 per share.	Directo	1.388.788	12 nov 2021	69.740
RUSSELL ALAN J Officer and Director	Sale at price 19.62 - 20.70 per share.	Directo	583.823	08 nov 2021	29.451
RUSSELL ALAN J Officer and Director	Sale at price 17.43 - 19.42 per share.	Directo	789.909	03 nov 2021	44.172
RUSSELL ALAN J Officer and Director	Sale at price 18.00 - 18.18 per share.	Directo	130.483	15 oct 2021	7.182
RUSSELL ALAN J Officer and Director	Sale at price 18.02 per share.	Directo	22.885	11 oct 2021	1.270
RUSSELL ALAN J Other Executive	Sale at price 18.03 - 18.56 per share.	Directo	386.743	08 oct 2021	21.028
RUSSELL ALAN J Officer	Sale at price 18.00 - 18.26 per share.	Directo	105.409	05 oct 2021	5.778
RUSSELL ALAN J Officer and Director	Sale at price 16.83 - 17.47 per share.	Directo	452.483	29 sept 2021	26.454
RUSSELL ALAN J Officer and Director	Sale at price 17.98 - 19.42 per share.	Directo	1.071.422	27 sept 2021	58.546
ROOT JONATHAN D Director	Purchase at price 31.22 per share.	Directo	487.812	30 mar 2021	15.625
ROOT JONATHAN D Director		Indirecto		30 mar 2021	3.473.543
FLYNN JAMES E Beneficial Owner of more than 10% of a Class of Security	Purchase at price 31.22 per share.	Indirecto	19.512.500	30 mar 2021	625.000
FLYNN JAMES E Beneficial Owner of more than 10% of a Class of Security		Indirecto		30 mar 2021	3.308.137
THOMPSON PETER A Director and Beneficial Owner of more than 10% of a Class of Security	Purchase at price 31.22 per share.	Indirecto	11.219.688	30 mar 2021	359.375
THOMPSON PETER A Director and Beneficial Owner of more than 10% of a Class of Security		Indirecto		30 mar 2021	13.002.760
NOVO HOLDINGS A/S Beneficial Owner of more than 10% of a Class of Security	Purchase at price 31.22 per share.	Directo	19.512.500	30 mar 2021	625.000
NOVO HOLDINGS A/S Beneficial Owner of more than 10% of a Class of Security		Directo		30 mar 2021	4.962.207
ORBIMED ADVISORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 31.22 per share.	Indirecto	11.219.688	30 mar 2021	359.375
ORBIMED ADVISORS, L.L.C. Beneficial Owner of more than 10% of a Class of Security		Indirecto		30 mar 2021	13.002.760
WELLINGTON BIOMEDICAL INNOVATION MASTER INVESTORS CAYMAN I L Beneficial Owner of more than 10% of a Class of Security		Directo		30 mar 2021	681.812

IBEX 3511.297,80-31,20(-0,28%)

Euro Stoxx 505.034,39+9,22(+0,18%)

Dólar/Euro1,0831+0,0004(+0,03%)

Petróleo Brent81,92+0,02(+0,02%)

Oro2.346,00-46,90(-1,96%)

Bitcoin EUR62.666,77-2.087,21(-3,22%)

Edgewise Therapeutics, Inc. (EWTX)

Transacciones de accionistas miembros de la empresa

Transacciones comunicadas por la persona con información privilegiada: últimos dos años

IBEX 35
11.297,80
-31,20(-0,28%)

Euro Stoxx 50
5.034,39
+9,22(+0,18%)

Dólar/Euro
1,0831
+0,0004(+0,03%)

Petróleo Brent
81,92
+0,02(+0,02%)

Oro
2.346,00
-46,90(-1,96%)

Bitcoin EUR
62.666,77
-2.087,21(-3,22%)